By Dennis Thompson HealthDay ReporterWEDNESDAY, Jan. 7, 2026 (HealthDay News) — Ozempic and Wegovy might help people avoid ...

For years, researchers have noted an alarming rise in colorectal cancer in younger people that’s not fully explained away by ...

A recent study shows that bacteria living inside colorectal tumors form distinct ecosystems that are closely linked to how ...

Increased stiffness in the colon may encourage the development and progression of early-onset colorectal cancer, a new study shows.

The findings are particularly relevant for India, where colorectal cancer is emerging as a growing public health concern ...

GLP-1 receptor agonists may be superior to aspirin for primary prevention of colorectal cancer, according to study results ...

Aspirin use in patients with PIK3CA-mutated colorectal cancer reduces recurrence risk by over 50%, found a study published in the Journal of Clinical Oncology. The findings could lead to immediate ...

A new study published in the International Journal of Cancer might add some extra encouragement to everyone trying to keep ...

In this analysis of colorectal cancer patients from 2 clinical trials, researchers aimed to assess the effect of physical activity on overall survival.

Company closed $22M financing to support randomized Phase 2b trial; IND cleared and study initiated; Interim results anticipated in late 2026; topline data expected in H2/2027 ...

Noetik CEO and co-founder Ron Alfa, M.D., Ph.D., said the licensing of human foundation models is “a new paradigm in biotech.” With the GSK deal validating the paradigm, in Alfa’s view, Noetik ...